Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d)
Condition(s):Irritable Bowel SyndromeLast Updated:July 30, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Irritable Bowel SyndromeLast Updated:July 30, 2018Completed
Condition(s):Irritable Bowel SyndromeLast Updated:September 4, 2018Completed
Condition(s):Myalgia; Hypercholesterolemia; HyperlipidemiaLast Updated:December 22, 2011Completed
Condition(s):Community-Acquired Bacterial Pneumonia (CABP)Last Updated:December 8, 2011Terminated
Condition(s):Irritable Bowel SyndromeLast Updated:October 22, 2019Completed
Condition(s):Complicated Skin and Skin Structure InfectionsLast Updated:December 16, 2011Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.